Provexis PLC (PXS)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

0.55p

Buy

0.60p

arrow-up0.012p (+2.09%)

Prices updated at 09 May 2024, 13:20 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Provexis PLC is engaged in developing and licensing the proprietary Fruitflow, which is a heart-health functional food ingredient for the functional food sector.
FTSE All-Share
arrow-up0.33%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
0.58
triangle-d
arrow-up
0.03 (+4.35%)
triangle-d
Today open
0.60
triangle-d
arrow-down
-0.01 (-2.17%)
triangle-d
Today, 13:20:47 BST
0.59
triangle-d
0.60p - 0.55p
0.90p - 0.41p
-
13.01m
-
750,000
4,780,915
13.24
895,151.96
0.53
2,217.82m
GB00B0923P27
0.00
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.